Maria J. Salazar-Rodriguez
Santa Cruz De Tenerife, CN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Laboratory Prognostic Index (LAB-PI) in diffuse large B-cell lymphoma: a single blood analysis predicts outcomes as good as IPI, NCCN-IPI, and GELTAMO-IPI.
Journal: ESMO open
Published: February 05, 2025
A low lymphocyte-to-monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis.
Journal: British journal of haematology
Published: October 24, 2024
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Journal: British journal of haematology
Published: March 07, 2023
Salmonella Typhi Vaccination Response as a Tool for the Stratification of Risk in Patients with Predominantly Antibody Deficiencies.
Journal: Diagnostics (Basel, Switzerland)
Published: August 26, 2022
Intramuscular Anti-D treatment for immune thrombocytopenia: A single centre experience.
Journal: British journal of haematology
Published: May 08, 2022
New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO).
Journal: British journal of haematology
Published: September 02, 2019
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 19, 2019
Differential prognostic impact of GELTAMO-IPI in cell of origin subtypes of Diffuse Large B Cell Lymphoma as defined by the Hans algorithm.
Journal: British journal of haematology
Published: March 12, 2018
Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β2 -microglobulin yields a more accurate GELTAMO-IPI.
Journal: British journal of haematology
Published: July 20, 2016
Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years.
Journal: Annals of hematology
Published: May 23, 2016
Pruritic maculopapular rash and diarrhea syndrome in a patient with acute lymphoblastic leukemia in relapse
Journal: Enfermedades infecciosas y microbiologia clinica
Published: September 16, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026